Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: Multivariate analysis

Journal of Surgical Oncology

Volumn 82, Issue 1, 2003, Pages 34-50

  Vora, Hemangini H ^a   Shah, Neelam G ^a   Patel, Devendra D ^a   Trivedi, Trupti I ^a   Chikhlikar, Priya R ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

C myc; Early stage and locally advanced stage tongue cancer; FVIII RA; Prognostic factor

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; CYTOKERATIN 19; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONCOGENE C ERB; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADULT; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS P21(RAS); REGRESSION ANALYSIS; SURVIVAL RATE; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037219333     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10183     Document Type: Article

References (46)

1. Brachman DG: Molecular biology of head and neck cancer. Semin Oncol 1994;21:320-329.
2. Field JK, Spandidos DA, Malliri A, et al.: Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991;64:573-577.
3. Watling DL, Gown AM, Coltrera MD: Over-expression of p53 in head and neck cancer. Head Neck 1992;14:437-444.
4. Kaur J, Srivastava A, Rathan R: Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int J Cancer 1994;54:340-345.
5. Saranath D, Tandle AT, Teni TR, et al.: p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncol Eur J Cancer 1999;35:242-250.
6. Partridge M, Kiguwa S, Emilion G, et al.: New insights into p53 protein stabilisation in oral squamous cell carcinoma. Oral Oncol Eur J Cancer 1999;35:45-55.
7. Saranath D, Panchal RG, Nair R, et al.: Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 1989;80:430-437.
8. Somers KD, Cartwright SL, Schechter GI: Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 1990;5:915-920.
9. Merritt WD, Weissler MC, Turk BF, et al.: Oncogene amplification in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1990;116:1394-1398.
10. Leonard JH, Kearsley JH, Chenevix-Trench G, et al.: Analysis of gene amplification in head and neck squamous cell carcinomas. Int J Cancer 1991;48:511-515.
11. Williams ME, Gaffey MJ, Weiss LM, et al.: Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993;119:1238-1243.
12. Muller D, Million R, Lidereau R, et al.: Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer 1994;2:113-120.
13. Callender T, El-Naggar AK, Lee MS, et al.: PRAD-1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994;74:152-158.
14. Michalides R, van Veelen N, Hart A, et al.: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-978.
15. van der Velden LA, Schaafsma E, Manni JJ, et al.: Cytokeratin expression in normal and (pre)malignant head and neck epithelia: An overview. Head Neck 1993;15:133 -146.
16. Jordan RCK, Catzavelos GC, Barrett AW, et al.: Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Oral Oncol Eur J Cancer 1996;32B:394-400.
17. Saranath D, Chang SE, Bhoite LT, et al.: High frequency mutations in codons 12 and 61 of H-ras oncogene in chewing tobacco related human oral carcinoma in India. Br J Cancer 1991;63:573-578.
18. Field JK: Oncogenes and tumor-suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol Eur J Cancer 1992;28B:67-76.
19. Xia W, Lau Y-K, Zhang H-Z, et al.: Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 1997;3:3-9.
20. Weidner N: Tumor angiogenesis: Review of current applications in tumor progonstication. Semin Diagn Pathol 1993;10:302-313.
21. UICC: TNM classification of malignant tumors. UICC Technical Report Series 1980;5:2.
22. Broders AC: Microscopic grading of cancer. Surg Clin North Am 1941;21:947-962.
23. Patel DD, Bhatavdekar JM, Chikhlikar PR, et al.: Node negative breast carcinoma: Hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators. J Surg Oncol 1996;62:86-92.
24. Weidner N, Semple JP, Welch WR, et al.: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
25. Bhatavdekar JM, Patel DD, Chikhlikar PR, et al.: Overexpression of CD44: A useful independent predictor of prognosis in patients with colorectal carcinomas. Ann Surg Oncol 1998;5:495-501.
26. Norusis MJ: In SPSS for Windows: Advanced Statistics, Release 6.0. Chicago, IL: SPSS, 1993.
27. Harris CC: P53 tumor suppressor gene: From the basic research laboratory to the clinic - An abridged historical perspective. Carcinogenesis 1996;17:1187-1198.
28. Chen TM, Defendi V: Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Oncogene 1992;7:1541-1547.
29. Xu J, Gimenez-Conti IB, Cunningham JE, et al.: Alterations of p53, cyclin DI, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998;83:204-212.
30. El-Deiry WS, Tokino T, Velculescu VE, et al.: WAF-1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
31. Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059-1065.
32. Frank JL, Bur ME, Garb JL, et al.: p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 1994;73:181-186.
33. Sauter ER, Ridge JA, Trock B, et al.: Overexpression of the p53 gene in primary and metastatic head and neck carcinomas. Laryngoscope 1995;105:653-656.
34. Wilson GD, Grover R, Reachman PL, et al.: Bcl-2 expression correlates with favorable outcome in head and neck cancer treated by accelerated radiotherapy. Cancer Res 1996;16:2403-2408.
35. Giatromanolaki A, Koukourakis M, Zaramboukas T, et al.: p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy. Anticancer Res 1998;18:4685-4692.
36. Vaidya MM, Sawant SS, Borges AM, et al.: Cytokeratin expression in precancerous lesions of the human oral cavity. Oral Oncol Eur J Cancer 1998;34:261-264.
37. Azuma M, Furumoto N, Kawamata H, et al.: The relation of ras oncogene product p21 expression to clinico pathological status and clinical outcome in squamous cell head and neck cancer. Cancer J 1987;1:375-380.
38. Field JK, Spandidos DA, Yagnisis M, et al.: C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res 1992;12:613-620.
39. Williams JK, Carlson GW, Cohen C, et al.: Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994;168:373-380.
40. Gasparini G, Weidner N, Maluta S, et al.: Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous cell carcinoma. Int J Cancer 1993;55:739-744.
41. Zatterstrom UK, Brun E, Willen R, et al.: Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 1995;17:312-318.
42. Gleich LL, Biddinger PW, Pavelic ZP, et al.: Tumor angigonesis in T1 oral cavity squamous cell carcinoma: Role in predicting tumor aggressiveness. Head Neck 1996;18:343-346.
43. Gleich LL, Biddinger PW, Duperier FD, et al.: Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: A clinical-pathologic correlation. Head Neck 1997;19:276-280.
44. Field JK, Spandidos DA, Stell PM, et al.: Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 1989;4:1463-1468.
45. Masuda M, Hirakawa N, Nakashima T, et al.: Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 1996;78:390-395.
46. Tsuji T, Sasaki K, Hiraoka F, et al.: The immunohistochemical detection of ras p21 and its correlation with differentiation in oral cancers. J Tumor Marker Oncol 1989;4:415-419.